Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Treatment of acute gout: a systematic review.

Khanna PP, Gladue HS, Singh MK, FitzGerald JD, Bae S, Prakash S, Kaldas M, Gogia M, Berrocal V, Townsend W, Terkeltaub R, Khanna D.

Semin Arthritis Rheum. 2014 Aug;44(1):31-8. doi: 10.1016/j.semarthrit.2014.02.003. Review.

PMID:
24650777
2.

Diagnosis and management of acute gout.

Conway N, Schwartz S.

Med Health R I. 2009 Nov;92(11):356-8. Review.

PMID:
19999893
3.

The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors.

Wechalekar MD, Vinik O, Moi JH, Sivera F, van Echteld IA, van Durme C, Falzon L, Bombardier C, Carmona L, Aletaha D, Landewé RB, van der Heijde DM, Buchbinder R.

J Rheumatol Suppl. 2014 Sep;92:15-25. doi: 10.3899/jrheum.140458. Review.

PMID:
25180124
4.

Management of acute and chronic gouty arthritis: present state-of-the-art.

Schlesinger N.

Drugs. 2004;64(21):2399-416. Review.

PMID:
15481999
5.

A literature review of the epidemiology and treatment of acute gout.

Kim KY, Ralph Schumacher H, Hunsche E, Wertheimer AI, Kong SX.

Clin Ther. 2003 Jun;25(6):1593-617. Review.

PMID:
12860487
6.

[Therapy of hyperuricemia and gout].

Pöllmann G, Kullich W, Klein G.

Wien Med Wochenschr. 1997;147(16):382-7. Review. German.

PMID:
9446417
7.

Managing problem gout.

Fam AG.

Ann Acad Med Singapore. 1998 Jan;27(1):93-9. Review.

PMID:
9588282
8.

Canakinumab for the Patient With Difficult-to-Treat Gouty Arthritis: Review of the Clinical Evidence.

Bardin T.

Joint Bone Spine. 2015 Oct;82 Suppl 1:eS9-16. doi: 10.1016/S1297-319X(15)30003-8. Review.

PMID:
26717801
9.

Colchicine for acute gout.

Schlesinger N, Schumacher R, Catton M, Maxwell L.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006190. Review. Update in: Cochrane Database Syst Rev. 2014;8:CD006190.

PMID:
17054279
10.

Colchicine and other drugs for gout.

[No authors listed]

Med Lett Drugs Ther. 2009 Nov 30;51(1326):93-4. Review. No abstract available.

PMID:
20224523
11.

Overview of the management of acute gout and the role of adrenocorticotropic hormone.

Schlesinger N.

Drugs. 2008;68(4):407-15. Review.

PMID:
18318560
12.

[Gout and hyperuricaemia--should both be treated?].

Uhlig T.

Tidsskr Nor Laegeforen. 2003 Oct 23;123(20):2878-80. Review. Norwegian.

PMID:
14600714
13.

A new perspective on the pharmacoeconomics of colchicine.

Wertheimer AI, Davis MW, Lauterio TJ.

Curr Med Res Opin. 2011 May;27(5):931-7. doi: 10.1185/03007995.2011.563284. Review.

PMID:
21370937
14.

Updates in the management of gout.

Keith MP, Gilliland WR.

Am J Med. 2007 Mar;120(3):221-4. Review.

PMID:
17349440
15.

Current concepts in the treatment of gouty arthritis.

Fang ZH, Waizy H.

Orthop Surg. 2013 Feb;5(1):6-12. doi: 10.1111/os.12024. Review.

PMID:
23420740
16.

Prophylaxis for acute gout flares after initiation of urate-lowering therapy.

Latourte A, Bardin T, Richette P.

Rheumatology (Oxford). 2014 Nov;53(11):1920-6. doi: 10.1093/rheumatology/keu157. Review.

PMID:
24758886
17.

Advances in the management of gout and hyperuricaemia.

Hoskison TK, Wortmann RL.

Scand J Rheumatol. 2006 Jul-Aug;35(4):251-60. Review.

PMID:
16882587
18.

The inflammatory process of gout and its treatment.

Cronstein BN, Terkeltaub R.

Arthritis Res Ther. 2006;8 Suppl 1:S3. Review.

PMID:
16820042
19.

Systemic corticosteroids for acute gout.

Janssens HJ, Lucassen PL, Van de Laar FA, Janssen M, Van de Lisdonk EH.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005521. doi: 10.1002/14651858.CD005521.pub2. Review.

PMID:
18425920
20.

Discussion following cases 4 and 5.

Croft JD.

Am J Med. 2006 Nov;119(11 Suppl 1):S16-9. No abstract available.

PMID:
17059906
Items per page

Supplemental Content

Support Center